SLC6A3 and Parkinson disease: In patients with DIP there has not been observed a dopamine deficit in comparison with those with Parkinson’s disease, whose DAT level in the striatum nucleus is significantly lower even in the early stages (Shin and Chung, 2012; Pa et al., 2021).